延长移植物存活时间的蛋白酶抑制剂在一项美国的研究中发现，西格玛公司开发的不可逆特异性丝氨酸蛋白酶抑制剂Ｎ－对甲苯磺酰基－Ｌ－赖氨酰氯甲基酮（ＴＬＣＫ）在大鼠异体心脏移植模型中可延长同种心脏移植存活时间。研究人员称，这是首例在体内研究证明对血管器官同种... Protease inhibitors to prolong graft survival In a U.S. study it was found that the irreversible specific serine protease inhibitor N-p-toluenesulfonyl-L-lysyl chloromethyl ketone (TLCK), developed by Sigma-Aldrich, Allograft heart transplant model can extend the survival time of allograft heart transplantation. Researchers say this is the first in vivo study to demonstrate that blood vessel organs are homogenous ...